Ke Fu
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Epidemiology 12
- Liver Disease Diagnosis and Treatment 12
- Co-authors
- Cheng Ma (17 shared papers)Lihong Gong (16 shared papers)Honglin Zhou (14 shared papers)Yafang Zhang (12 shared papers)Yunxia Li (4 shared papers)Yunxia Li (15 shared papers)Yuqin Guo (2 shared papers)Cheng Wang (1 shared paper)
In The Last Decade
Ke Fu
40 papers receiving 1.4k citations
Ke Fu's Hit Papers
Peers
Comparison fields: 5 of 117
- Hepatology 143
- Pharmacology 129
- Complementary and alternative medicine 118
- Immunology 197
- Cancer Research 129
Countries citing papers authored by Ke Fu
This map shows the geographic impact of Ke Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Fu more than expected).
Fields of papers citing papers by Ke Fu
This network shows the impact of papers produced by Ke Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Fu. The network helps show where Ke Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Macrophage Polarization and Its Role in Liver Disease Hit paper breakdown → | 2021 | 432 |
| 2 | 2023 | 88 | |
| 3 | 2022 | 71 | |
| 4 | 2023 | 63 | |
| 5 | 2023 | 56 | |
| 6 | 2021 | 52 | |
| 7 | 2020 | 50 | |
| 8 | 2022 | 47 | |
| 9 | 2022 | 44 | |
| 10 | 2023 | 38 | |
| 11 | 2021 | 37 | |
| 12 | 2021 | 35 | |
| 13 | 2022 | 34 | |
| 14 | 2020 | 29 | |
| 15 | 2022 | 28 | |
| 16 | 2023 | 27 | |
| 17 | 2022 | 27 | |
| 18 | 2021 | 25 | |
| 19 | 2022 | 21 | |
| 20 | 2022 | 18 |
About Ke Fu
Ke Fu is a scholar working on Molecular Biology, Epidemiology, Complementary and alternative medicine, Pharmacology and Hepatology, having authored 41 papers that have together received 1.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (12 papers), Liver physiology and pathology (7 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Traditional Chinese Medicine Analysis (5 papers), Neurological Disease Mechanisms and Treatments (4 papers), Liver Disease and Transplantation (4 papers), Phytochemistry and Biological Activities (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Hepatology (143 citations), Pharmacology (129 citations), Complementary and alternative medicine (118 citations), Immunology (197 citations) and Cancer Research (129 citations). Ke Fu has collaborated with scholars based in China and Thailand. Frequent co-authors include Cheng Ma, Lihong Gong, Honglin Zhou, Yafang Zhang, Yunxia Li, Yunxia Li, Yuqin Guo, Cheng Wang, Cheng Wang and Cheng Peng. Their work appears in journals such as Biomedicine & Pharmacotherapy, Frontiers in Pharmacology, Journal of Ethnopharmacology, Pharmacological Research and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.